Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for ...

Researchers say standard depression screening tools often check for physical symptoms, but weren't designed for those with ...

There are around 7,000 cases of the aggressive disease in the UK every year and 4,000 deaths. Around one woman dies every two ...

And now a new study by researchers at the University of Iowa has found physical symptoms of ovarian cancer are often being ...